Evidence map›Paper›PMID 19237299›Full record

ReviewCytokine2009

Signals for the execution of Th2 effector function.

Deborah J Fowell

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Signaling pathways critical for allergic airway inflammation.Current opinion in allergy and clinical immunology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Deborah J FowellDavid H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Avenue, Box 609, Rochester, NY 14642, USA. Deborah_Fowell@urmc.rochester.edu
University of Rochester · US

Funding

Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue SiteR01AI072690 · NIAID · UNIVERSITY OF ROCHESTER · PI FOWELL, DEBORAH J · 2008 to 2020
$3.6M
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue SiteR37AI072690 · NIAID · CORNELL UNIVERSITY · PI Deborah J Fowell · 2023 to 2026
$1.9M
The Role of Itk in Th DifferentiationR01AI050201 · NIAID · UNIVERSITY OF ROCHESTER · PI FOWELL, DEBORAH J · 2001 to 2005
$1.6M
NIAID NIH HHS AI072690NIAID NIH HHS AI50201NIAID NIH HHS R01 AI050201NIAID NIH HHS R01 AI072690NIAID NIH HHS R37 AI072690
6 · The paper itself

Abstract

Appropriate control of infection depends on the generation of lymphocytes armed with a particular array of cytokine and chemokine effector molecules. The differentiation of naïve T cells into functionally distinct effector subsets is regulated by signals from the T cell receptor (TCR) and cytokine receptors. Using gene knock-out approaches, the initiation of discrete effector programs appears differentially sensitive to the loss of individual TCR signaling components; likely due to differences in the transcription factors needed to activate individual cytokine genes. Less well understood however, are the signal requirements for the execution of effector function. With a focus on Th2 cells and the kinase ITK, we review recent observations that point to differences between the signals needed for the initiation and implementation of cytokine programs in CD4+ T cells. Indeed, Th2 effector cells signal differently from both their naïve counterparts and from Th1 effectors suggesting they may transduce activation signals differently or may be selectively receptive to different activation signals. Potential regulation points for effector function lie at the level of transcription and translation of cytokine genes. We also discuss how provision of these execution signals may be spatially segregated in vivo occurring at tissue sites of inflammation and subject to modulation by the pathogen itself.

Indexed as

AnimalsCD4-Positive T-LymphocytesCytokinesHumansImmune SystemInflammationInterleukin-4LigandsLymph NodesModels, BiologicalSignal TransductionTh2 CellsTranscription FactorsCytokinesInterleukin-4LigandsTranscription Factors

Identifiers

PMID19237299
PMCPMC2955979
OpenAlexW2035034597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.